Asia-Pacific Colorectal Cancer Therapeutics Market Will at a CAGR of 6% and Reach USD 7.9 Billion in 2024, Growing from $5.3 Billion in 2017
Colorectal cancer (CRC) is the most common cancer and the leading cause of cancer-related mortality globally. The five-year prevalence population for CRC in Asia-Pacific was 1.7 million in 2017. This figure has been gradually rising with the growing elderly population and increasingly Westernized lifestyles.
View full press release